Supira Medical announced today that it began patient enrollment in a U.S. early feasibility trial of its percutaneous ventricular assist device (pVAD). The Shifamed portfolio company plans to evaluate the pVAD in patients undergoing high-risk percutaneous coronary intervention (HRPCI). Los Gatos, California-based Supira’s study looks at the safety and feasibility of the low-profile, high-flow device. […]
supiramedical
Supira Medical announces first in-human use of pVAD
Supira Medical announced today that it initiated the first-in-human clinical study of its percutaneous ventricular assist device (pVAD). Los Gatos, California-based Supira, a Shifamed portfolio company, is using the pVAD in a prospective, single-arm, single-center study. It will evaluate the safety and performance of the low-profile, high-flow pVAD. Can Supira’s pVAD support cardiovascular hemodynamics in […]
Supira Medical closes $35m Series B for its pVAD tech
Supira Medical announced that it closed a $35 million Series B financing round and appointed Nitin Salunke as its new president & CEO. Cormorant Asset Management led the financing, which officially closed on Feb. 25. The Capital Partnership, 415 Capital, AMED Ventures and Shifamed Angels all participated as well. Campbell, Calif.-based Supira Medical said in […]
Newly formed pVAD dev Supira Medical raises $16m
Medtech incubator Shifamed said this week that its newly formed portfolio company Supira Medical has raised $15.5 million in a new round of financing. The round was led by The Capital Partnership and joined by Cormorant Asset Management and Shifamed Angels, the Campbell, Calif.-based incubator said. The round officially closed on April 25. Supira Medical […]
